By vgreene, 5 June, 2019 Epocrates’ standard for inclusion in the Common Reactions section is to include all adverse drug reactions (ADRs) and lab abnormalities reported in at least 2% of patients at any recommended dose for any indication and occurring more frequently in the tre
By vgreene, 5 June, 2019 The Pregnancy/Lactation section of Epocrates drug monographs includes clinical details on risks during pregnancy and breastfeeding. When relevant, information about impact on contraception and fertility, pregnancy testing, and contact details for pregnanc
By vgreene, 5 June, 2019 The Safety/Monitoring section of Epocrates drug monographs includes special content directly related to the safe use and safety monitoring of the drug. This section includes laboratory and objective, safety monitoring parameters. Additional content includ
By vgreene, 5 June, 2019 The Contraindications/Cautions section of Epocrates drug monographs includes diseases, conditions, and other circumstances in which the drug should not generally be used or should be used with caution.Epocrates doesn’t limit contraindications and cautions
By vgreene, 5 June, 2019 The Formulations section of Epocrates OTC monographs includes available formulations for the drug and the amount of each active ingredient in each formulation. For soft oral formulations (eg, oral liquids, chewables, dissolvables, etc), flavors and the pr
By vgreene, 5 June, 2019 Available dosage strengths and formulations are listed at the top of each Adult and Peds Dosing section of Epocrates drug monographs in the Dosage Forms field. This field includes a list of dosage forms, each followed by the available strengths with the a
By vgreene, 5 June, 2019 Periodically, some of these obsolete brand-name monographs (generally those with less recognized names) are removed from Epocrates to optimize app space on handheld devices and because removing obsolete information makes sense given our focus on providing
By vgreene, 5 June, 2019 What does Epocrates do when brand-name drug products are removed from the market?